AstraZeneca Backs Up Call To Toss Seroquel Claims
In response to demands for detail by the judge overseeing product liability litigation over its blockbuster drug Seroquel, drug maker AstraZeneca has submitted a 42-page brief to justify its calls to...To view the full article, register now.
Already a subscriber? Click here to view full article